[1]
Arun Daniel, Atanu Kundu, Balamurugan, Bhabani Bhuyan, and Chaitanya Challa, “Combination dual therapy of Empagliflozin and Linagliptin for the management of Type 2 Diabetes”, Med. res. chronicles, vol. 7, no. 1, pp. 41-44, Feb. 2020.